Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Back on the scent: the olfactory system in CNS demyelinating diseases.
Longitudinal extensive transverse myelitis and optic neuritis: the elements for the diagnosis of neuromyelitis optica.
Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs.
Overlapping demyelinating syndromes and anti-NMDA receptor encephalitis.
Tumor necrosis factor beta (TNF-β) NcoI polymorphism is associated with multiple sclerosis in Caucasian patients from Southern Brazil independently from HLA-DRB1.
CD8-mediated inflammatory central nervous system disorders.
Regulatory effects of fisetin on microglial activation.
Detection of inflammatory biomarkers in saliva and urine: Potential in diagnosis, prevention, and treatment for chronic diseases.
Callosal atrophy in multiple sclerosis is related to cognitive speed.
Small Molecules in Stem Cell Research.
Determinants of the severity of comorbid migraine in multiple sclerosis.
Autoreactive CD19+CD20- Plasma Cells Contribute to Disease Severity of Experimental Autoimmune Encephalomyelitis.
Antinuclear antibodies in pediatric acquired demyelinating diseases of the central nervous system.
Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study.
G protein-coupled receptor 30 contributes to improved remyelination after cuprizone-induced demyelination.
MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS.
[Transorbital echography for assessment of optical nerve atrophy in demyelinating diseases: a pilot study].
Aspirin and multiple sclerosis.
Impact of acupuncture by using life-energy (qi) oriental needle on the paralysis of rats with experimental autoimmune encephalomyelitis.
White matter atrophy and cognitive dysfunctions in neuromyelitis optica.
ATX-MS-1467 in Patients With Relapsing Forms of Multiple Sclerosis
Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.
Low dose naltrexone for induction of remission in Crohn's disease.
Effects of Imatinib Mesylate in Mouse Models of Multiple Sclerosis and In vitro Determinants.
Soluble adenylyl cyclase is necessary and sufficient to overcome the block of axonal growth by myelin-associated factors.
Pages
« first
‹ previous
…
175
176
177
178
179
180
181
182
183
…
next ›
last »